EW

SELL

Edwards Lifesciences Corporatio

Healthcare · Rank #138 · Analyzed Apr 20, 2026

$80.99

Current Price

$29.09

Intrinsic Value

-51.7%

Upside/Downside

4/10

Score

4/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score4/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 51.7%

Fair Value Range

Low$14.34

Base (IV)$29.09

High$39.13

Entry Points

Conservative$14.34

Moderate$21.72

Aggressive$29.09

Quality & Moat Breakdown

Return on Equity10.4% → 0.5/1.0

Debt LevelD/E 7 → 1.0/1.0

Revenue QualityGrowth 19.4%, margin Δ-32.0% +recovery → 1.0/1.0

Moat Strength2.5/5 → 0.5/1.0

Profit Margins17.7% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.